期刊文献+

高亲和力抗eGFP纳米抗体的筛选与应用

Screening and application of high affinity eGFP nanobodies
在线阅读 下载PDF
导出
摘要 将增强型绿色荧光蛋白(Enhanced Green Fluorescent Protein,eGFP)免疫羊驼后构建纳米抗体免疫库,固相淘选eGFP纳米抗体;构建E.coli Rosetta表达载体,诱导表达纳米抗体,并鉴定其结合活性及特异性;辣根过氧化物酶(Horseradish peroxidase,HRP)标纳米抗体,确定其工作浓度及稳定性;将纳米抗体与纳米磁珠偶联应用于免疫沉淀B13-EGFP融合蛋白。四免后抗血清滴度超过1.28×10^(6),获得库容量为1.85×10^(8) cfu的抗eGFP纳米抗体噬菌体展示文库;原核表达10种独特基因序列的纳米抗体,均为可溶性表达;采用ForteBio Octet确定出纳米抗体4-28与eGFP的亲和常数(KD)最高,达到9.67×10^(-11)M;纳米抗体4-28与eGFP、绿色荧光蛋白(Green Fluorescent Protein,GFP)特异性结合;HRP标记纳米抗体4-28检测范围是1:10000~1:25000(浓度100~40 ng·mL^(-1)),比市场上现有的检测二抗(稀释范围1:5000~1:20000)灵敏度更高;纳米抗体4-28偶联羧基化纳米磁珠,免疫沉淀B13-eGFP融合蛋白,实现了简单快速分离目的蛋白B13-eGFP。 The peripheral blood of eGFP immunized alpaca was used to construct a nanobody immune library,and the eGFP nanobody was solid-phase panned.The E.coli Rosetta expression vector was constructed and expressed nanobody.The binding activity and specificity of nanobody were identified.The working concentration and stability of the enzyme-labeled nanobody was verified after HRP enzyme-labeled nanobody.The nanobody and nanomagnetic beads were coupled to obtain the B13-EGFP fusion protein by immunoprecipitation.After four immunizations,the antiserum titer exceeded 1.28×10^(6) and the eGFP nanobody library with a storage capacity of 1.85×10^(8) cfu was obtained.Nanobodies of ten unique gene sequences were expressed in prokaryotic cells,and they were all soluble intracellularly.Nanobodies 4-28 have the best affinity constant(KD)with eGFP by ForteBio Octet,reaching 9.67×10^(-11)M;Nanobody 4-28 specifically binds with eGFP and GFP.The detection range of the HRP enzyme-labeled nanobody 4-28 was 110000~125000(100~40 ng·mL^(-1)),which is higher than existing detection secondary antibodies on the market(dilution range 15000~120000).Nanobody 4-28 was coupled with carboxylated magnetic nanobeads to immunoprecipitate the B13-eGFP fusion protein,leading to a simple and rapid separation of the target protein B13-eGFP.
作者 刘晓芳 刘贝 周方月 黄云祥 钟引凤 张茹云 梁宇芳 王丹 付金衡 LIU Xiaofang;LIU Bei;ZHOU Fangyue;HUANG Yunxiang;ZHONG Yinfeng;ZHANG Ruyun;LIANG Yufang;WANG Dan;FU Jinheng(Institute of Life Sciences,Nanchang University,Nanchang 330031,China;Sino-Germany Joint Research Institute,Nanchang University,Nanchang 330047,China;Jiangxi Agricultural University,Nanchang 330045,China)
出处 《南昌大学学报(理科版)》 CAS 北大核心 2021年第1期34-40,共7页 Journal of Nanchang University(Natural Science)
基金 国家自然科学基金资助项目(31471648)。
关键词 纳米抗体 EGFP 噬菌体展示 ELISA IP Nanobody eGFP Phage display ELISA IP
  • 相关文献

参考文献2

  • 1M.Ablikim,M.N.Achasov,P.Adlarson,S.Ahmed,M.Albrecht,M.Alekseev,A.Amoroso,F.F.An,Q.An,Y.Bai,O.Bakina,R.Baldini Ferroli,Y.Ban,K.Begzsuren,J.V.Bennett,N.Berger,M.Bertani,D.Bettoni,F.Bianchi,J Biernat,J.Bloms,I.Boyko,R.A.Briere,L.Calibbi,H.Cai,X.Cai,A.Calcaterra,G.F.Cao,N.Cao,S.A.Cetin,J.Chai,J.F.Chang,W.L.Chang,J.Charles,G.Chelkov,Chen,G.Chen,H.S.Chen,J.C.Chen,M.L.Chen,S.J.Chen,Y.B.Chen,H.Y.Cheng,W.Cheng,G.Cibinetto,F.Cossio,X.F.Cui,H.L.Dai,J.P.Dai,X.C.Dai,A.Dbeyssi,D.Dedovich,Z.Y.Deng,A.Denig,Denysenko,M.Destefanis,S.Descotes-Genon,F.De Mori,Y.Ding,C.Dong,J.Dong,L.Y.Dong,M.Y.Dong,Z.L.Dou,S.X.Du,S.I.Eidelman,J.Z.Fan,J.Fang,S.S.Fang,Y.Fang,R.Farinelli,L.Fava,F.Feldbauer,G.Felici,C.Q.Feng,M.Fritsch,C.D.Fu,Y.Fu,Q.Gao,X.L.Gao,Y.Gao,Y.Gao,Y.G.Gao,Z.Gao,B.Garillon,I.Garzia,E.M.Gersabeck,A.Gilman,K.Goetzen,L.Gong,W.X.Gong,W.Gradl,M.Greco,L.M.Gu,M.H.Gu,Y.T.Gu,A.Q.Guo,F.K.Guo,L.B.Guo,R.P.Guo,Y.P.Guo,A.Guskov,S.Han,X.Q.Hao,F.A.Harris,K.L.He,F.H.Heinsius,T.Held,Y.K.Heng,Y.R.Hou,Z.L.Hou,H.M.Hu,J.F.Hu,T.Hu,Y.Hu,G.S.Huang,J.S.Huang,X.T.Huang,X.Z.Huang,Z.L.Huang,N.Huesken,T.Hussain,W.Ikegami Andersson,W.Imoehl,M.Irshad,Q.Ji,Q.P.Ji,X.B.Ji,X.L.Ji,H.L.Jiang,X.S.Jiang,X.Y.Jiang,J.B.Jiao,Z.Jiao,D.P.Jin,S.Jin,Y.Jin,T.Johansson,N.Kalantar-Nayestanaki,X.S.Kang,R.Kappert,M.Kavatsyuk,B.C.Ke,I.K.Keshk,T.Khan,A.Khoukaz,P.Kiese,R.Kiuchi,R.Kliemt,L.Koch,O.B.Kolcu,B.Kopf,M.Kuemmel,M.Kuessner,A.Kupsc,M.Kurth,M.G.Kurth,W.Kuhn,J.S.Lange,P.Larin,L.Lavezzi,H.Leithoff,T.Lenz,C.Li,Cheng Li,D.M.Li,F.Li,F.Y.Li,G.Li,H.B.Li,H.J.Li,J.C.Li,J.W.Li,Ke Li,L.K.Li,Lei Li,P.L.Li,P.R.Li,Q.Y.Li,W.D.Li,W.G.Li,X.H.Li,X.L.Li,X.N.Li,X.Q.Li,Z.B.Li,H.Liang,H.Liang,Y.F.Liang,Y.T.Liang,G.R.Liao,L.Z.Liao,J.Libby,C.X.Lin,D.X.Lin,Y.J.Lin,B.Liu,B.J.Liu,C.X.Liu,D.Liu,D.Y.Liu,F.H.Liu,Fang Liu,Feng Liu,H.B.Liu,H.M.Liu,Huanhuan Liu,Huihui Liu,J.B.Liu,J.Y.Liu,K.Y.Liu,Ke Liu,Q.Liu,S.B.Liu,T.Liu,X.Liu,X.Y.Liu,Y.B.Liu,Z.A.Liu,Zhiqing Liu,Y.F.Long,X.C.Lou,H.J.Lu,J.D.Lu,J.G.Lu,Y.Lu,Y.P.Lu,C.L.Luo,M.X.Luo,P.W.Luo,T.Luo,X.L.Luo,S.Lusso,X.R.Lyu,F.C.Ma,H.L.Ma,L.L.Ma,M.M.Ma,Q.M.Ma,X.N.Ma,X.X.Ma,X.Y.Ma,Y.M.Ma,F.E.Maas,M.Maggiora,S.Maldaner,S.Malde,Q.A.Malik,A.Mangoni,Y.J.Mao,Z.P.Mao,S.Marcello,Z.X.Meng,J.G.Messchendorp,G.Mezzadri,J.Min,T.J.Min,R.E.Mitchell,X.H.Mo,Y.J.Mo,C.Morales Morales,N.Yu.Muchnoi,H.Muramatsu,A.Mustafa,S.Nakhoul,Y.Nefedov,F.Nerling,I.B.Nikolaev,Z.Ning,S.Nisar,S.L.Niu,S.L.Olsen,Q.Ouyang,S.Pacetti,Y.Pan,M.Papenbrock,P.Patteri,M.Pelizaeus,H.P.Peng,K.Peters,A.A.Petrov,J.Pettersson,J.L.Ping,R.G.Ping,A.Pitka,R.Poling,V.Prasad,M.Qi,T.Y.Qi,S.Qian,C.F.Qiao,N.Qin,X.P.Qin,X.S.Qin,Z.H.Qin,J.F.Qiu,S.Q.Qu,K.H.Rashid,C.F.Redmer,M.Richter,M.Ripka,A.Rivetti,V.Rodin,M.Rolo,G.Rong,J.L.Rosner,Ch.Rosner,M.Rump,A.Sarantsev,M.Savrie,K.Schoenning,W.Shan,X.Y.Shan,M.Shao,C.P.Shen,P.X.Shen,X.Y.Shen,H.Y.Sheng,X.Shi,X.D Shi,J.J.Song,Q.Q.Song,X.Y.Song,S.Sosio,C.Sowa,S.Spataro,F.F.Sui,G.X.Sun,J.F.Sun,L.Sun,S.S.Sun,X.H.Sun,Y.J.Sun,Y.K Sun,Y.Z.Sun,Z.J.Sun,Z.T.Sun,Y.T Tan,C.J.Tang,G.Y.Tang,X.Tang,V.Thoren,B.Tsednee,I.Uman,B.Wang,B.L.Wang,C.W.Wang,D.Y.Wang,H.H.Wang,K.Wang,L.L.Wang,L.S.Wang,M.Wang,M.Z.Wang,Wang Meng,P.L.Wang,R.M.Wang,W.P.Wang,X.Wang,X.F.Wang,X.L.Wang,Y.Wang,Y.F.Wang,Z.Wang,Z.G.Wang,Z.Y.Wang,Zongyuan Wang,T.Weber,D.H.Wei,P.Weidenkaff,H.W.Wen,S.P.Wen,U.Wiedner,G.Wilkinson,M.Wolke,L.H.Wu,L.J.Wu,Z.Wu,L.Xia,Y.Xia,S.Y.Xiao,Y.J.Xiao,Z.J.Xiao,Y.G.Xie,Y.H.Xie,T.Y.Xing,X.A.Xiong,Q.L.Xiu,G.F.Xu,L.Xu,Q.J.Xu,W.Xu,X.P.Xu,F.Yan,L.Yan,W.B.Yan,W.C.Yan,Y.H.Yan,H.J.Yang,H.X.Yang,L.Yang,R.X.Yang,S.L.Yang,Y.H.Yang,Y.X.Yang,Yifan Yang,Z.Q.Yang,M.Ye,M.H.Ye,J.H.Yin,Z.Y.You,B.X.Yu,C.X.Yu,J.S.Yu,C.Z.Yuan,X.Q.Yuan,Y.Yuan,A.Yuncu,A.A.Zafar,Y.Zeng,B.X.Zhang,B.Y.Zhang,C.C.Zhang,D.H.Zhang,H.H.Zhang,H.Y.Zhang,J.Zhang,J.L.Zhang,J.Q.Zhang,J.W.Zhang,J.Y.Zhang,J.Z.Zhang,K.Zhang,L.Zhang,S.F.Zhang,T.J.Zhang,X.Y.Zhang,Y.Zhang,Y.H.Zhang,Y.T.Zhang,Yang Zhang,Yao Zhang,Yi Zhang,Yu Zhang,Z.H.Zhang,Z.P.Zhang,Z.Q.Zhang,Z.Y.Zhang,G.Zhao,J.W.Zhao,J.Y.Zhao,J.Z.Zhao,Lei Zhao,Ling Zhao,M.G.Zhao,Q.Zhao,S.J.Zhao,T.C.Zhao,Y.B.Zhao,Z.G.Zhao,A.Zhemchugov,B.Zheng,J.P.Zheng,Y.Zheng,Y.H.Zheng,B.Zhong,L.Zhou,L.P.Zhou,Q.Zhou,X.Zhou,X.K.Zhou,Xingyu Zhou,Xiaoyu Zhou,Xu Zhou,A.N.Zhu,J.Zhu,J.Zhu,K.Zhu,K.J.Zhu,S.H.Zhu,W.J.Zhu,X.L.Zhu,Y.C.Zhu,Y.S.Zhu,Z.A.Zhu,J.Zhuang,B.S.Zou,J.H.Zou,无.Future Physics Programme of BESⅢ[J].Chinese Physics C,2020,44(4). 被引量:547
  • 2蔡召忠,陈萍,邓守恒.PEP-1-VP3融合蛋白的分离纯化与初步鉴定[J].华西药学杂志,2015,30(2):160-162. 被引量:1

二级参考文献10

  • 1Lanz HL, Zimmerman RM, Brouwer J, et al. Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin [ J]. Cell Death Dis,2013,7(4) :487 -490.
  • 2Li J, Wang H, Ma Z, et al. TAT - Apoptin induces apoptosis in the human bladder cancer EJ cell line and regulates Bax, Bcl - 2, caspase -3 and survivin expression [ J ]. Exp Ther Med, 2012,3(6) :1033 - 1035.
  • 3Wang F,Wang Y,Zhang X. Recent progress of cell - penetrating peptides as new carriers for intracellular cargo delivery [ J ]. J Control Release ,2014,28 ( 174 ) : 126 - 128.
  • 4Tisseyre C, Bahembera E, Dardevet L, et al. Cell penetration prop- erties of a highly efficient mini maurocalcine Peptide [ J ]. Phar- maceuticals ,2013,6 ( 3 ) :320 - 325.
  • 5Yuan L, Zhang L, Dong X, et al. Apoptin selectively induces the apoptosis of tumor cells by suppressing the transcription of HSP70 [ J]. Tumour Biol,2013,34( 1 ) :577 -579.
  • 6Zhang M, Wang J, Li C, et al. Potent growth - inhibitory effect of a dual cancer - specific oncolytic adenovirus expressing apoptin on prostate carcinoma [ J ] Int J Oncol, 2013,42 ( 3 ) : 1052 - 1055.
  • 7Zhuang SM, Shvarts A, van Ormondt H, et al. Apoptin, a protein derived from chicken anemia virus, induces p53 - independent apoptosis in human osteosarcoma ceils[ J]. Cancer Res, 1995,55 (3) :486 -489.
  • 8Danen- van Oomehot AA, van der Eb A J, Notebom MHM. BCL - 2 stimulates apoptin - induced apoptosis [ J ]. Adv Exp Med Biol, 1999,457 (10) :245 - 248.
  • 9Park H J, Shin J, Kim J, et al. Nonviral delivery for reprogramming to pluripotency and differentiation [J] , Arch Pharm Res,2014, 37(1) :107 -109.
  • 10Gros E, Deshayes S, Morris MC, et al. Non - covalent peptide - based strategy for protein and peptide nucleic acid transduction [J]. Biochim Biophys Acta,2006,1758 ( 3 ) :384 - 287.

共引文献546

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部